Insights
More Articles
- EUnetHTA21 Launches Joint Scientific Consultations for Regulators, HTAs, and Sponsors
- Funding Established for Canadian Drug Agency Transition Office
- Using Community Reporters as a Strategic Source for Evaluating Vaccine Effectiveness
- Advanced Analytics Drives Innovation in Pharmacovigilance Risk Management Systems
- Smart Safety Surveillance (3S): A Proven Approach to Building Functional LMIC Pharmacovigilance Systems
Smart Safety Surveillance (3S): A Proven Approach to Building Functional LMIC Pharmacovigilance Systems
Smart Safety Surveillance (3S) is a product-focused, principles-based approach to building functional LMIC (low- and middle-income countries) pharmacovigilance (PV) systems that has been validated across multiple products and geographies.
×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!